US2023256040A1PendingUtilityA1
Composition for prevention or treatment of neurological or mental disorders comprising extracellular vesicles derived from lactobacillus paracasei
Est. expiryJun 16, 2040(~13.9 yrs left)· nominal 20-yr term from priority
Inventors:Yoon-Keun Kim
A61K 35/747A61P 25/00A61K 35/744A23L 33/135A23V 2002/00A23V 2200/316A23V 2200/322A23V 2200/3262A23V 2200/328A23V 2200/332A61P 3/00A61P 21/00A61P 25/18
73
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are a method for preventing, improving, or treating a neurological disorder, mental disorder, senescence, or symptoms thereof, comprising administering to a subject in need thereof vesicles derived from Lactobacillus paracasei as an active ingredient, and a pharmaceutical or functional food composition comprising the vesicles
Claims
exact text as granted — not AI-modified1 .- 17 . (canceled)
18 . A method for alleviating or treating a mental disorder, the method comprising administering a composition comprising vesicles derived from Lactobacillus paracasei as an active ingredient to an individual in need thereof.
19 . The method of claim 18 , wherein the mental disorder is selected from the group consisting of anxiety disorders, post-traumatic stress disorder (PTSD), panic disorder, depression, autism spectrum disorder, attention deficit/hyperactivity disorder (ADHD), schizophrenia, and a combination thereof.
20 . The method of claim 18 , wherein the vesicles have an average diameter of 10 to 1000 nm.
21 . The method of claim 18 , wherein the vesicles are isolated from a Lactobacillus paracasei culture solution.
22 . The method of claim 18 , wherein the vesicles are isolated from a food composition comprising Lactobacillus paracasei.
23 . The method of claim 18 , wherein the vesicles are naturally or artificially secreted from Lactobacillus paracasei.
24 . The method of claim 18 , wherein the composition is a pharmaceutical composition.
25 . The method of claim 18 , wherein the composition is a food composition.
26 . The method of claim 18 , wherein the composition is an inhalation composition.Join the waitlist — get patent alerts
Track US2023256040A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.